SSS

SHEDIR PHARMA GROUP

No trades
See on Supercharts
Market capitalization
‪41.83 M‬EUR
‪5.70 M‬EUR
‪59.39 M‬EUR
‪1.43 M‬
Beta (1Y)
0.30

About SHEDIR PHARMA GROUP

CEO
Antonio Scala
Headquarters
Piano di Sorrento
Founded
2014
ISIN
IT0005379620
FIGI
BBG00PNYV7M0
Shedir Pharma Group SpA operates as a holding company which engages in the research and development of nutraceuticals and medical devices. It operates through the BU1 and BU2 business units. The BU1 unit focuses on the development, formulation, promotion, and marketing of nutraceuticals, dermocosmetics, and medical equipment. The BU2 unit specializes in the production and distribution of medicines and other pharmaceuticals. The company was founded by Umberto di Maio on October 13, 2014 and is headquartered in Piano di Sorrento, Italy.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SHE is 3.64 EUR — it has decreased by 0.55% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange SHEDIR PHARMA GROUP stocks are traded under the ticker SHE.
SHE stock is 3.33% volatile and has beta coefficient of 0.30. Check out the list of the most volatile stocks — is SHEDIR PHARMA GROUP there?
Yes, you can track SHEDIR PHARMA GROUP financials in yearly and quarterly reports right on TradingView.
SHE stock hasn't changed in a week, the month change is a 4.21% fall, over the last year SHEDIR PHARMA GROUP has showed a 26.91% decrease.
SHE net income for the last quarter is ‪4.52 M‬ EUR, while the quarter before that showed ‪1.18 M‬ EUR of net income which accounts for 282.15% change. Track more SHEDIR PHARMA GROUP financial stats to get the full picture.
Today SHEDIR PHARMA GROUP has the market capitalization of ‪41.61 M‬, it has increased by 0.54% over the last week.
Yes, SHE dividends are paid annually. The last dividend per share was 0.17 EUR. As of today, Dividend Yield (TTM)% is 4.81%. Tracking SHEDIR PHARMA GROUP dividends might help you take more informed decisions.
Like other stocks, SHE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHEDIR PHARMA GROUP stock right from TradingView charts — choose your broker and connect to your account.
SHE reached its all-time high on Aug 27, 2019 with the price of 8.80 EUR, and its all-time low was 2.70 EUR and was reached on Jul 6, 2022.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHEDIR PHARMA GROUP technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHEDIR PHARMA GROUP stock shows the strong sell signal. See more of SHEDIR PHARMA GROUP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHEDIR PHARMA GROUP EBITDA is ‪5.32 M‬ EUR, and current EBITDA margin is 20.81%. See more stats in SHEDIR PHARMA GROUP financial statements.